For the past decade, the Business Development and Global Alliances teams at Celgene have worked hard to find and cultivate partnerships to benefit patients worldwide. Our partnerships encompass early academic research collaborations, in-licensing of promising technology platforms and assets, and late stage acquisitions. To date, we have formed 50+ collaborations around the world and, through our alliance management efforts, recently brought our first partnered drug to market through this distributed research model.
At Celgene, we have adopted a progressive R&D model focused on external innovation to ensure patients benefit from the latest technologies. We are constantly evaluating collaboration opportunities that complement our internal research efforts and strategically align with our mission and vision.
We approach potential partnerships with an enabling mindset. As part of this, we intentionally craft structures and terms which provide critical financial and human capital to our partners to accelerate the development of new therapies, while also providing them the independence to innovate. Our goal is to empower companies to leverage their nimbleness in early development to create win-win scenarios for both our partners and our company.
We are passionate about serving patients and the importance of sustaining and spreading innovation throughout the world has never been greater. Our success is dependent on our ability to develop effective collaborative solutions from an “ecosystem of innovation” – bringing together industry partners, patients, healthcare providers, academia, payers and policymakers – to find solutions that can change the world for the better.
In Business Development and Global Alliances, we are focused on maximizing the value of our partnerships based on specialized alliance management capabilities, expertise and decision-making tools to advance our programs for patients. By working together with our partners, we can change the course of human health so that diseases can be prevented, diagnosed early, successfully managed, or cured.